SECreport

Form 4 IMMUNE PHARMACEUTICALS For: May 17 Filed by: Fiorino Anthony S.

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations